Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
ABBOTT MEDICAL · Decision date Sep 11, 2026
What did the FDA decide?
The FDA record for P140009/S140, a 30-Day Notice categorized as a process change involving a manufacturer, sterilizer, packager or supplier, describes an approval to use an alternate third-tier supplier for FR-4 material. That material goes into manufacturing the printed circuit boards for the Chargers of the Eterna SCS IPG and Liberta RC DBS IPG. The applicant listed is Abbott Medical, the device category is an implanted electrical stimulator for parkinsonian tremor, the specialty is Neurology, and the product code is MHY.
The identifier P140009 links the notice to the original PMA and frames it as a supplement, not a new approval of the whole system. The supplied statement does not identify the supplier, describe qualification testing, or present data on safety or effectiveness; its reported purpose is a supplier change, which is not itself independent proof of either. The decision date field reads 2026-09-11.
FDA approval order statement
approval to utilize an alternate third-tier supplier for the FR-4 material, which is used in the manufacture of the printed circuit boards for the Chargers of the Eterna SCS IPG and Liberta RC DBS IPG
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Sep 11, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P140009/S140
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- MHY
- Decision code
- OK30
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.
- Applicant
- Abbott Medical
- Product code
- MHY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140009 · Original PMA
BRIO NEUROSTIMULATION SYSTEM
P140009/S140 received
Application receipt date recorded by FDA.
P140009/S140 · FDA decision
30-Day Notice
P140009/S139 · Related supplement
Infinity DBS IPG
P140009/S143 · Related supplement
Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator
P140009/S141 · Related supplement
Deep Brain Stimulation (DBS) EPG
P140009/S142 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger
P140009/S144 · Related supplement
Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)
Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BRIO NEUROSTIMULATION SYSTEMP140009 | ABBOTT MEDICAL | PMA approval | Jun 12, 2015 | FDA |
Infinity DBS IPGP140009/S139 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Deep Brain Stimulation (DBS) EPGP140009/S141 | ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MHY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Nov 8, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA | |
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEMP960009/S546 | Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6901 Prestion Rd., Plano, TX, 75024
Sources and methodology
- Original FDA record: P140009/S140
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
